Satter Muneer A 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-08 4:04 pm Purchase |
2021-01-06 | 13D | Aileron Therapeutics, Inc. ALRN |
Satter Muneer A | 1,017,040 19.900% |
450,000 (+79.36%) |
Filing |
| 2020-06-09 5:13 pm Purchase |
2020-06-08 | 13D | Aileron Therapeutics, Inc. ALRN |
Satter Muneer A | 567,040 19.900% |
185,000 (+48.42%) |
Filing |